Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals (USA) develops biopharma treatments for unmet medical needs, marketed HETLIOZ, Fanapt, Ponvory, with a pipeline of sleep, psychiatric, oncology and rare disease agents, targeting US, EU, Israel markets.

Headquarters: United States (USA)

Vanda Pharmaceuticals Inc. Logo
Company Profile
  • Employees: 368
  • HQ: Washington
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
VNDA Vanda Pharmaceuticals Inc.
Cap: 0.4B
EQUITY NMS USD US9216591084 Active
📈
Home Login